---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-031985"
form_type: "8-K"
ticker: "TARA"
cik: "0001359931"
company_name: "Protara Therapeutics, Inc."
filed_at: "2022-06-09T23:59:59+00:00"
generated_at: "2026-06-25T03:05:52.018381+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Protara Therapeutics shareholders elect three directors, ratify auditor, approve say-on-pay at 2022 annual meeting

## Summary
- Elected Luke Beshar, Roger Garceau, and Gregory Sargen as Class II directors to serve until 2025 annual meeting.
- Ratified Ernst & Young as independent registered public accounting firm for fiscal year ending Dec 31, 2022 with 8,385,650 votes for.
- Advisory vote approved compensation of named executive officers with 6,426,881 votes for, 126,276 against, 54,902 abstentions.

## SEC filing metadata
- accession: 0001213900-22-031985
- form_type: 8-K
- ticker: TARA
- cik: 0001359931
- company_name: Protara Therapeutics, Inc.
- filed_at: 2022-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1359931/000121390022031985/0001213900-22-031985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1359931/000121390022031985/ea161338-8k_protara.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-031985
- JSON: https://secwatch.observer/filing/0001213900-22-031985.json
- Plain text: https://secwatch.observer/filing/0001213900-22-031985.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.